SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211458
Filing Date
2013-05-09
Accepted
2013-05-09 17:21:41
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d511409d10q.htm 10-Q 581151
2 EX-10.1 d511409dex101.htm EX-10.1 113763
3 EX-10.2 d511409dex102.htm EX-10.2 62162
4 EX-10.3 d511409dex103.htm EX-10.3 10174
5 EX-31.1 d511409dex311.htm EX-31.1 6804
6 EX-31.2 d511409dex312.htm EX-31.2 6792
7 EX-32.1 d511409dex321.htm EX-32.1 4298
8 EX-32.2 d511409dex322.htm EX-32.2 4280
  Complete submission text file 0001193125-13-211458.txt   3986072

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT srpt-20130331.xml EX-101.INS 459016
10 XBRL TAXONOMY EXTENSION SCHEMA srpt-20130331.xsd EX-101.SCH 43900
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srpt-20130331_cal.xml EX-101.CAL 48217
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srpt-20130331_def.xml EX-101.DEF 224757
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20130331_lab.xml EX-101.LAB 320531
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20130331_pre.xml EX-101.PRE 266977
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 13830071
SIC: 2834 Pharmaceutical Preparations